6–24 hours (short-acting, e.g., Xanax) / 1–4 days (long-acting, e.g., Valium)
- — Rebound anxiety
- — insomnia
- — tremor
- — sweating
Benzodiazepines — including alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) — are prescribed for anxiety, insomnia, and seizure disorders.
Benzodiazepines — including alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) — are prescribed for anxiety, insomnia, and seizure disorders. Long-term or high-dose use can produce physiological dependence, tolerance, and a substance use disorder. Benzodiazepine withdrawal is potentially dangerous and, like alcohol, can cause seizures — making medically supervised taper the clinical standard.
Also known as: benzo addiction, Xanax addiction, Klonopin addiction, Ativan addiction, Valium addiction.
Every person's experience varies. The windows below describe typical clinical patterns — your care team adjusts the plan based on how you respond.
Abrupt cessation of benzodiazepines can cause seizures and is dangerous. Gradual taper under clinical supervision — often cross-tapering to a long-acting benzodiazepine — is the standard of care.
Residential care supports patients through extended tapers and provides structured treatment of the anxiety or trauma that often underlies benzodiazepine use.
CBT, DBT, and trauma-focused therapy address the conditions for which benzodiazepines were originally prescribed — preventing relapse to medication after taper.
PHP, IOP, and outpatient maintain clinical contact through the extended post-taper window when protracted symptoms may still emerge.
Benzodiazepine prescribing rates in Kentucky remain above the national average, and benzodiazepines are frequently present in polysubstance overdoses alongside opioids. Safe, medically supervised taper is essential to prevent withdrawal-related seizures.
Kentucky Medicaid plans typically cover medically supervised benzodiazepine taper in detox, residential, PHP, IOP, and outpatient settings. Because tapers can extend for weeks to months, step-down coverage and coordinated outpatient care are especially important.
Coverage is determined by medical necessity using ASAM criteria. Our admissions team verifies your specific plan during your first call.
No. Abrupt discontinuation of benzodiazepines can cause seizures and is potentially life-threatening, particularly after long-term or high-dose use. Always work with a clinician on a structured taper.
Tapers are individualized based on dose, duration of use, and patient response. Typical medically supervised tapers range from several weeks to several months; some patients with long-term or high-dose use require slower tapers.
Yes. Kentucky Medicaid plans typically cover medically supervised benzodiazepine taper across the ASAM continuum when medically necessary.
24/7 admissions. Insurance verification in minutes. Most KY Medicaid plans accepted. No judgment, no pressure, no obligation.